Discovery of a cooperative mode of inhibiting RIPK1 kinase
Open Access
- 1 June 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Discovery
- Vol. 7 (1), 1-18
- https://doi.org/10.1038/s41421-021-00278-x
Abstract
RIPK1, a death domain-containing kinase, has been recognized as an important therapeutic target for inhibiting apoptosis, necroptosis, and inflammation under pathological conditions. RIPK1 kinase inhibitors have been advanced into clinical studies for the treatment of various human diseases. One of the current bottlenecks in developing RIPK1 inhibitors is to discover new approaches to inhibit this kinase as only limited chemotypes have been developed. Here we describe Necrostatin-34 (Nec-34), a small molecule that inhibits RIPK1 kinase with a mechanism distinct from known RIPK1 inhibitors such as Nec-1s. Mechanistic studies suggest that Nec-34 stabilizes RIPK1 kinase in an inactive conformation by occupying a distinct binding pocket in the kinase domain. Furthermore, we show that Nec-34 series of compounds can synergize with Nec-1s to inhibit RIPK1 in vitro and in vivo. Thus, Nec-34 defines a new strategy to target RIPK1 kinase and provides a potential option of combinatorial therapy for RIPK1-mediated diseases.Keywords
This publication has 44 references indexed in Scilit:
- Structural Basis of RIP1 Inhibition by NecrostatinsStructure, 2013
- Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease modelsCell Death & Disease, 2012
- Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 KinaseCell, 2012
- Hydrogen exchange mass spectrometry for studying protein structure and dynamicsChemical Society Reviews, 2010
- Target Identification by Diazirine Photo‐Cross‐Linking and Click ChemistryCurrent Protocols in Chemical Biology, 2009
- RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to NecrosisScience, 2009
- Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced InflammationCell, 2009
- Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-αCell, 2009
- Identification of RIP1 kinase as a specific cellular target of necrostatinsNature Chemical Biology, 2008
- Regulation of Protein Kinases: Controlling Activity through Activation Segment ConformationMolecular Cell, 2004